In Uncategorized Posted
TBVI Awardees 2025
With the TBVI Award, TBVI encourages promising scientists and rewards their remarkable contributions to tuberculosis (TB) vaccine research and development, by offering them the opportunity to [...]
In Uncategorized Posted
TBVI Awards 2025
Would you like to present your work at the TBVI Annual Symposium? To encourage promising scientists and recognise outstanding contributions to TB vaccine research and development, TBVI presents [...]
In Uncategorized Posted
Mycobacterium tuberculosis vaccine candidates selected to assess efficacy in a mouse model
Following the call for vaccine researchers to submit their vaccine candidate for testing in a mouse model, we are delighted to announce the selection of three candidates. Based on predetermined [...]
In Uncategorized Posted
Second annual progress meeting MTBVACN3
On May 27-28 2024, the second progress meeting of the MTBVACN3 project took place in Pilanesberg, near Johannesburg in South Africa. During these days the consortium partners met to share [...]
In Uncategorized Posted
Biofabri and TBVI sign a contract with the European Health and Digital Executive Agency to accelerate the final development of the new TB vaccine MTBVAC
Biofabri and TBVI have signed a contract with the European Health and Digital Executive Agency (HaDEA) under the EU4Health Programme to accelerate the final development of the MTBVAC vaccine. [...]